- Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
-
Cheong HR, Woo HY, Heo J, Yoon KT, Kim DU, Kim GH, Kang DH, Song GA, Cho M
- KMID: 1782219
- Korean J Hepatol.
- 2010 Mar;16(1):38-48.
- doi: 10.3350/kjhep.2010.16.1.38
BACKGROUND/AIMS: The combination therapy of peginterferon (PEG-IFN) and ribavirin is the standard treatment for hepatitis C virus (HCV) infection. However, few trials have involved patients with cirrhosis. The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
